Differences

Last edited on March 4, 2021

This shows you the differences between two versions of the page.

--- child:genetic-disorders:digeorge-syndrome-22q11.2-22q-deletion [on April 12, 2019]
+++ child:genetic-disorders:digeorge-syndrome-22q11.2-22q-deletion [on April 17, 2019]
@@ Line 31: / Line 31: @@
 <callout type="danger" title="Antipsychotics Can Mask Early-Onset Parkinson's Symptoms in DiGeorge + Schizophrenia Patients" icon="true">
-Individuals with DiGeorge have a higher risk for early-onset [[geri:parkinsons|Parkinson's Disease]].[([[https://www.ncbi.nlm.nih.gov/pubmed/24018986|Butcher, N. J., Kiehl, T. R., Hazrati, L. N., Chow, E. W., Rogaeva, E., Lang, A. E., & Bassett, A. S. (2013). Association between early-onset Parkinson disease and 22q11. 2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA neurology, 70(11), 1359-1366.]])] As a result, individuals with concomitant schizophrenia and on long-term antipsychotic treatment may have their emerging Parkinson's symptoms masked and mistakenly attributed as [[meds:side-effects:eps|extrapyramidal symptoms]].
+Individuals with DiGeorge have a higher risk for early-onset [[geri:parkinsons|Parkinson's Disease]].[([[https://www.ncbi.nlm.nih.gov/pubmed/24018986|Butcher, N. J., Kiehl, T. R., Hazrati, L. N., Chow, E. W., Rogaeva, E., Lang, A. E., & Bassett, A. S. (2013). Association between early-onset Parkinson disease and 22q11. 2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA neurology, 70(11), 1359-1366.]])] As a result, individuals with concomitant schizophrenia and on long-term antipsychotic treatment may have their emerging Parkinson's symptoms masked and mistakenly attributed as [[meds:antipsychotics:eps|extrapyramidal symptoms]].
 </callout>
 ===== Pathophysiology =====